BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18079726)

  • 21. Macrolide- and tetracycline-adjustable siRNA-mediated gene silencing in mammalian cells using polymerase II-dependent promoter derivatives.
    Malphettes L; Fussenegger M
    Biotechnol Bioeng; 2004 Nov; 88(4):417-25. PubMed ID: 15382105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inclusion of a matrix-attached region in a 7SK pol III vector increases the efficiency of shRNA-mediated gene silencing in embryonic carcinoma cells.
    Sotirova VN; Calciano MA; Krueger W; Lalande M
    Plasmid; 2006 May; 55(3):216-26. PubMed ID: 16439020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
    von Eije KJ; ter Brake O; Berkhout B
    J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of tetracycline-responsive recombinant protein production and effect on cell growth and ER stress in mammalian cells.
    Jones J; Nivitchanyong T; Giblin C; Ciccarone V; Judd D; Gorfien S; Krag SS; Betenbaugh MJ
    Biotechnol Bioeng; 2005 Sep; 91(6):722-32. PubMed ID: 15981277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditional expression of vaccinia virus genes in mammalian cell lines expressing the tetracycline repressor.
    Hedengren-Olcott M; Hruby DE
    J Virol Methods; 2004 Sep; 120(1):9-12. PubMed ID: 15234804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vector-based RNAi approaches for stable, inducible and genome-wide screens.
    Fewell GD; Schmitt K
    Drug Discov Today; 2006 Nov; 11(21-22):975-82. PubMed ID: 17055406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tight control of transcription in Toxoplasma gondii using an alternative tet repressor.
    van Poppel NF; Welagen J; Duisters RF; Vermeulen AN; Schaap D
    Int J Parasitol; 2006 Apr; 36(4):443-52. PubMed ID: 16516216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of short hairpin RNA expression vectors to study mammalian neural development.
    Yu JY; Wang TW; Vojtek AB; Parent JM; Turner DL
    Methods Enzymol; 2005; 392():186-99. PubMed ID: 15644182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability in RNA interference in neuroendocrine PC12 cell lines stably transfected with an shRNA plasmid.
    Cahill AL; Moore JM; Sabar FI; Harkins AB
    J Neurosci Methods; 2007 Nov; 166(2):236-40. PubMed ID: 17767962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditional gene expression and knockdown using lentivirus vectors encoding shRNA.
    Szulc J; Aebischer P
    Methods Mol Biol; 2008; 434():291-309. PubMed ID: 18470652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA interference by expressing short hairpin RNA in the Ciona intestinalis embryo.
    Nishiyama A; Fujiwara S
    Dev Growth Differ; 2008 Aug; 50(6):521-9. PubMed ID: 18510713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene disruption by regulated short interfering RNA expression, using a two-adenovirus system.
    Kuninger D; Stauffer D; Eftekhari S; Wilson E; Thayer M; Rotwein P
    Hum Gene Ther; 2004 Dec; 15(12):1287-92. PubMed ID: 15684704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted transgenesis at the HPRT locus: an efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system.
    Palais G; Nguyen Dinh Cat A; Friedman H; Panek-Huet N; Millet A; Tronche F; Gellen B; Mercadier JJ; Peterson A; Jaisser F
    Physiol Genomics; 2009 Apr; 37(2):140-6. PubMed ID: 19141541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the tetracycline promoter system for regulated gene expression in Kluyveromyces marxianus.
    Pecota DC; Da Silva NA
    Biotechnol Bioeng; 2005 Oct; 92(1):117-23. PubMed ID: 15962338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditional mutant mice using tetracycline-controlled gene expression system in the brain.
    Aiba A; Nakao H
    Neurosci Res; 2007 Jun; 58(2):113-7. PubMed ID: 17316857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An advanced blue-white screening method for construction of shRNA expression vectors.
    Yang J; Xu J; Zhong X; Zhang Y; Wu Q; Li W; Zhang X; Zhen P; Yang X; Chen L; Wang Y; Zhu D; Zhai C; Ma L
    Biochem Biophys Res Commun; 2009 Dec; 390(1):97-102. PubMed ID: 19781525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short hairpin RNA targeted to dihydrofolate reductase enhances the immunoglobulin G expression in gene-amplified stable Chinese hamster ovary cells.
    Wu SC; Hong WW; Liu JH
    Vaccine; 2008 Sep; 26(38):4969-74. PubMed ID: 18602963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducibility of doxycycline-regulated gene in neural and neuroendocrine cells strongly depends on the appropriate choice of a tetracycline-responsive promoter.
    Klopotowska D; Strzadala L; Matuszyk J
    Neurochem Int; 2008 Jan; 52(1-2):221-9. PubMed ID: 17618706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expressing short hairpin RNAs in vivo.
    Snøve O; Rossi JJ
    Nat Methods; 2006 Sep; 3(9):689-95. PubMed ID: 16929313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.